Skip to content
777 Sourcing.

Capability

KCC2 discovery engine

Suppliers
1
States & provinces
1
Countries
1

1 kcc2 discovery engine supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

AXONIS THERAPEUTICS, INC.

BOSTON, MA

Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2, the critical mediator of inhibition within the brain. Its work translates breakthrough discoveries spun out from Boston Children's Hospital, Harvard and Laval University. The company has a proprietary KCC2 discovery engine and began first-in-human trials in 2024 for its first-in-class oral KCC2 potentiator drug, AXN-027, designed to restore functional inhibition to treat epilepsy, pain and other CNS pathologies.

drug discoverytarget biology

Compiled from public sources

Related capabilities

Other processes offered by the shops that list KCC2 discovery engine.

Browse all capabilities